<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="splice">
            
              <roleset id="splice.01" name="" wordnet="3">
                <roles>
                    <role n="0" descr="gene or RNA&#x09;&#x09;&#x09;&#x09;&#x09;&#x09;&#x0A;" />
                    <role n="1" descr="specific component in gene/RNA to get spliced&#x09;&#x09;&#x09;// eg. extron, intron //&#x0A;" />
                    <role n="2" descr="gene product&#x09;&#x09;&#x09;&#x09;&#x09;&#x09;&#x09;// mRNA //&#x0A;" />
                    <role n="3" descr="location referring to organelle, cell or tissue&#x0A;" />
                </roles>
                
                <example src="EGRAM" no="0">
                    <text>A caspase-2 minigene construct could be made that is alternatively spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="0">
                    <text>A caspase-2 minigene construct could be made to be alternatively spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="0">
                    <text>A caspase-2 minigene construct is able to be made that is alternatively spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="0">
                    <text>A caspase-2 minigene construct is observed to be made that is alternatively spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="0">
                    <text>A caspase-2 minigene construct has been shown to be made that is alternatively spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                
                <example src="EGRAM" no="1">
                    <text>A caspase-2 minigene construct is made that can be alternatively spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="2">
                    <text>A caspase-2 minigene construct was made that was alternatively spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="4">
                    <text>A caspase-2 minigene construct will be made that is alternatively spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="5">
                    <text>A caspase-2 minigene construct may be made that was alternatively spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="6">
                    <text>A caspase-2 minigene construct may have been made that can be alternatively spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="6">
                    <text>A caspase-2 minigene construct has the ability to be made to be alternatively spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="7">
                    <text>A caspase-2 minigene construct would be made that could be alternatively spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                
                <example src="EGRAM" no="0">
                    <text>A caspase-2 minigene construct could be made that is spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                  </example>
                  <example src="EGRAM" no="0">
                    <text>A caspase-2 minigene construct could be made to be spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                  </example>
                  <example src="EGRAM" no="0">
                    <text>A caspase-2 minigene construct is able to be made that is spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                  </example>
                  <example src="EGRAM" no="0">
                    <text>A caspase-2 minigene construct is observed to be made that is spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                  </example>
                  <example src="EGRAM" no="0">
                    <text>A caspase-2 minigene construct has been shown to be made that is spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                  </example>

                  <example src="EGRAM" no="1">
                    <text>A caspase-2 minigene construct is made that can be spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                  </example>
                  <example src="EGRAM" no="2">
                    <text>A caspase-2 minigene construct was made that was spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                  </example>
                  <example src="EGRAM" no="3">
                    <text>A caspase-2 minigene construct has been made that can be spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                  </example>
                  <example src="EGRAM" no="4">
                    <text>A caspase-2 minigene construct will be made that is spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                  </example>
                  <example src="EGRAM" no="5">
                    <text>A caspase-2 minigene construct may be made that was spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                  </example>
                  <example src="EGRAM" no="6">
                    <text>A caspase-2 minigene construct may have been made that can be spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                  </example>
                  <example src="EGRAM" no="6">
                    <text>A caspase-2 minigene construct has the ability to be made to be spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                  </example>
                  <example src="EGRAM" no="7">
                    <text>A caspase-2 minigene construct would be made that could be spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                  </example>
                
                <example src="EGRAM" no="*8">
                    <text>An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I has spliced only 20% as efficiently as RNA 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="*9">
                    <text>An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I splices only 20% as efficiently as RNA 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="*10">
                    <text>An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I will splice only 20% as efficiently as RNA 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="*10">
                    <text>An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I can splice only 20% as efficiently as RNA 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="*10">
                    <text>An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I may have spliced only 20% as efficiently as RNA 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="*10">
                    <text>An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I is able to splice only 20% as efficiently as RNA 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="*10">
                    <text>An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I is observed to splice only 20% as efficiently as RNA 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="*10">
                    <text>An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I has been shown to splice only 20% as efficiently as RNA 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="*10">
                    <text>An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I has the ability to splice only 20% as efficiently as RNA 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="*8">
                  <text>An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I has alternatively spliced only 20% as efficiently as RNA 3F (Fig.1 C Left).</text>
                  <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="*9">
                  <text>An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I alternatively splices only 20% as efficiently as RNA 3F (Fig.1 C Left).</text>
                  <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="*10">
                  <text>An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I will alternatively splice only 20% as efficiently as RNA 3F (Fig.1 C Left).</text>
                  <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="*10">
                  <text>An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I can alternatively splice only 20% as efficiently as RNA 3F (Fig.1 C Left).</text>
                  <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="*10">
                  <text>An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I may have alternatively spliced only 20% as efficiently as RNA 3F (Fig.1 C Left).</text>
                  <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="*10">
                  <text>An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I is able to alternatively splice only 20% as efficiently as RNA 3F (Fig.1 C Left).</text>
                  <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="*10">
                  <text>An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I is observed to alternatively splice only 20% as efficiently as RNA 3F (Fig.1 C Left).</text>
                  <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="*10">
                  <text>An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I has been shown to alternatively splice only 20% as efficiently as RNA 3F (Fig.1 C Left).</text>
                  <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="*10">
                  <text>An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I has the ability to alternatively splice only 20% as efficiently as RNA 3F (Fig.1 C Left).</text>
                  <arg n="2">RNA 3I</arg>
                </example>                
                
                <example src="EGRAM" no="12">
                    <text>Consequently, exon 30 with the intron has been spliced.</text>
                    <arg n="1">exon 30 with the intron</arg>
                </example>
                <example src="EGRAM" no="13">
                    <text>Consequently, exon 30 with the intron was spliced.</text>
                    <arg n="1">exon 30 with the intron</arg>
                </example>
                <example src="EGRAM" no="14">
                    <text>Consequently, exon 30 with the intron will be spliced.</text>
                    <arg n="1">exon 30 with the intron</arg>
                </example>
                <example src="EGRAM" no="15">
                    <text>Consequently, exon 30 with the intron may have been spliced.</text>
                    <arg n="1">exon 30 with the intron</arg>
                </example>
                <example src="EGRAM" no="16">
                    <text>Consequently, exon 30 with the intron can be spliced.</text>
                    <arg n="1">exon 30 with the intron</arg>
                </example>
                <example src="EGRAM" no="16">
                    <text>Consequently, exon 30 with the intron is able to be spliced.</text>
                    <arg n="1">exon 30 with the intron</arg>
                </example>
                <example src="EGRAM" no="16">
                    <text>Consequently, exon 30 with the intron is observed to be spliced.</text>
                    <arg n="1">exon 30 with the intron</arg>
                </example>
                <example src="EGRAM" no="16">
                    <text>Consequently, exon 30 with the intron has been shown to be spliced.</text>
                    <arg n="1">exon 30 with the intron</arg>
                </example>
                <example src="EGRAM" no="16">
                    <text>Consequently, exon 30 with the intron has the ability to be spliced.</text>
                    <arg n="1">exon 30 with the intron</arg>
                </example>
                <example src="EGRAM" no="12">
                  <text>Consequently, exon 30 with the intron, as our study suggested, has been spliced.</text>
                  <arg n="1">exon 30 with the intron, as our study suggested,</arg>
                </example>
                <example src="EGRAM" no="13">
                  <text>Consequently, exon 30 with the intron, as our study suggested, was spliced.</text>
                  <arg n="1">exon 30 with the intron, as our study suggested,</arg>
                </example>
                <example src="EGRAM" no="14">
                  <text>Consequently, exon 30 with the intron, as our study suggested, will be spliced.</text>
                  <arg n="1">exon 30 with the intron, as our study suggested,</arg>
                </example>
                <example src="EGRAM" no="15">
                  <text>Consequently, exon 30 with the intron, as our study suggested, may have been spliced.</text>
                  <arg n="1">exon 30 with the intron, as our study suggested,</arg>
                </example>
                <example src="EGRAM" no="16">
                  <text>Consequently, exon 30 with the intron, as our study suggested, can be spliced.</text>
                  <arg n="1">exon 30 with the intron, as our study suggested,</arg>
                </example>
                <example src="EGRAM" no="16">
                  <text>Consequently, exon 30 with the intron, as our study suggested, is able to be spliced.</text>
                  <arg n="1">exon 30 with the intron, as our study suggested,</arg>
                </example>
                <example src="EGRAM" no="16">
                  <text>Consequently, exon 30 with the intron, as our study suggested, is observed to be spliced.</text>
                  <arg n="1">exon 30 with the intron, as our study suggested,</arg>
                </example>
                <example src="EGRAM" no="16">
                  <text>Consequently, exon 30 with the intron, as our study suggested, has been shown to be spliced.</text>
                  <arg n="1">exon 30 with the intron, as our study suggested,</arg>
                </example>
                <example src="EGRAM" no="16">
                  <text>Consequently, exon 30 with the intron, as our study suggested, has the ability to be spliced.</text>
                  <arg n="1">exon 30 with the intron, as our study suggested,</arg>
                </example>
                
                <example src="EGRAM" no="17">
                    <text>Exons outside this size range are spliced into the mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">the mature mRNA</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>Exons outside this size range were spliced into the mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">the mature mRNA</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>Exons outside this size range have been spliced into the mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">the mature mRNA</arg>
                </example>
                
                <example src="EGRAM" no="18">
                    <text>Exons outside this size range may require additional exonic and/or intronic sequences to be spliced into the mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">the mature mRNA</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>Exons outside this size range require additional exonic and/or intronic sequences to be spliced into the mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">the mature mRNA</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>Exons outside this size range required additional exonic and/or intronic sequences to be spliced into the mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">the mature mRNA</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>Exons outside this size range have required additional exonic and/or intronic sequences to be spliced into the mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">the mature mRNA</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>Exons outside this size range may have required additional exonic and/or intronic sequences to be spliced into the mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">the mature mRNA</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>Exons outside this size range are able to require additional exonic and/or intronic sequences to be spliced into the mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">the mature mRNA</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>Exons outside this size range are observed to require additional exonic and/or intronic sequences to be spliced into the mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">the mature mRNA</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>Exons outside this size range have been shown to require additional exonic and/or intronic sequences to be spliced into the mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">the mature mRNA</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>Exons outside this size range have the probability of requiring additional exonic and/or intronic sequences to be spliced into the mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">the mature mRNA</arg>
                </example>
                
                <example src="EGRAM" no="17">
                  <text>Exons outside this size range are effectively spliced into the mature mRNA.</text>
                  <arg n="1">exons outside this size range</arg>
                  <arg n="2">the mature mRNA</arg>
                </example>
                <example src="EGRAM" no="18">
                  <text>Exons outside this size range were effectively spliced into the mature mRNA.</text>
                  <arg n="1">exons outside this size range</arg>
                  <arg n="2">the mature mRNA</arg>
                </example>
                <example src="EGRAM" no="18">
                  <text>Exons outside this size range have been effectively spliced into the mature mRNA.</text>
                  <arg n="1">exons outside this size range</arg>
                  <arg n="2">the mature mRNA</arg>
                </example>

                <example src="EGRAM" no="18">
                  <text>Exons outside this size range may require additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.</text>
                  <arg n="1">exons outside this size range</arg>
                  <arg n="2">the mature mRNA</arg>
                </example>
                <example src="EGRAM" no="18">
                  <text>Exons outside this size range require additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.</text>
                  <arg n="1">exons outside this size range</arg>
                  <arg n="2">the mature mRNA</arg>
                </example>
                <example src="EGRAM" no="18">
                  <text>Exons outside this size range required additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.</text>
                  <arg n="1">exons outside this size range</arg>
                  <arg n="2">the mature mRNA</arg>
                </example>
                <example src="EGRAM" no="18">
                  <text>Exons outside this size range have required additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.</text>
                  <arg n="1">exons outside this size range</arg>
                  <arg n="2">the mature mRNA</arg>
                </example>
                <example src="EGRAM" no="18">
                  <text>Exons outside this size range may have required additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.</text>
                  <arg n="1">exons outside this size range</arg>
                  <arg n="2">the mature mRNA</arg>
                </example>
                <example src="EGRAM" no="18">
                  <text>Exons outside this size range are able to require additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.</text>
                  <arg n="1">exons outside this size range</arg>
                  <arg n="2">the mature mRNA</arg>
                </example>
                <example src="EGRAM" no="18">
                  <text>Exons outside this size range are observed to require additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.</text>
                  <arg n="1">exons outside this size range</arg>
                  <arg n="2">the mature mRNA</arg>
                </example>
                <example src="EGRAM" no="18">
                  <text>Exons outside this size range have been shown to require additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.</text>
                  <arg n="1">exons outside this size range</arg>
                  <arg n="2">the mature mRNA</arg>
                </example>
                <example src="EGRAM" no="18">
                  <text>Exons outside this size range have the probability of requiring additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.</text>
                  <arg n="1">exons outside this size range</arg>
                  <arg n="2">the mature mRNA</arg>
                </example>
                
                <example src="EGRAM" no="19">
                    <text>However, a pre-mRNA containing mutations in SE2 has been spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="20">
                    <text>However, a pre-mRNA containing mutations in SE2 was spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="20">
                    <text>However, a pre-mRNA containing mutations in SE2 may have been spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="21">
                    <text>However, a pre-mRNA containing mutations in SE2 can be spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="22">
                    <text>However, a pre-mRNA containing mutations in SE2 is able to spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="23">
                    <text>However, a pre-mRNA containing mutations in SE2 is observed to be spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="24">
                    <text>However, a pre-mRNA containing mutations in SE2 has been shown to be spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="25">
                    <text>However, a pre-mRNA containing mutations in SE2 will be spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="25">
                    <text>However, a pre-mRNA containing mutations in SE2 has the ability to be spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="25">
                    <text>However, a pre-mRNA containing mutations in SE2 is likely to be spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                
                <example src="EGRAM" no="19">
                  <text>However, a pre-mRNA containing mutations in SE2 has been alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                  <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                  <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="20">
                  <text>However, a pre-mRNA containing mutations in SE2 was alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                  <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                  <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="20">
                  <text>However, a pre-mRNA containing mutations in SE2 is alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                  <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                  <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="20">
                  <text>However, a pre-mRNA containing mutations in SE2 may have been alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                  <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                  <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="21">
                  <text>However, a pre-mRNA containing mutations in SE2 can be alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                  <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                  <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="22">
                  <text>However, a pre-mRNA containing mutations in SE2 is able to alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                  <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                  <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="23">
                  <text>However, a pre-mRNA containing mutations in SE2 is observed to be alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                  <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                  <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="24">
                  <text>However, a pre-mRNA containing mutations in SE2 has been shown to be alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                  <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                  <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="25">
                  <text>However, a pre-mRNA containing mutations in SE2 will be alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                  <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                  <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="25">
                  <text>However, a pre-mRNA containing mutations in SE2 has the ability to be alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                  <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                  <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="25">
                  <text>However, a pre-mRNA containing mutations in SE2 is likely to be alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                  <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                  <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                
                              <example src="EGRAM" no="19">
                <text>A pre-mRNA containing mutations in SE2, however, has been alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                <arg n="1">the nt 3605 3 splice site</arg>
              </example>
              <example src="EGRAM" no="20">
                <text>A pre-mRNA containing mutations in SE2, however, was alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                <arg n="1">the nt 3605 3 splice site</arg>
              </example>
              <example src="EGRAM" no="20">
                <text>A pre-mRNA containing mutations in SE2, however, is alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                <arg n="1">the nt 3605 3 splice site</arg>
              </example>
              <example src="EGRAM" no="20">
                <text>A pre-mRNA containing mutations in SE2, however, may have been alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                <arg n="1">the nt 3605 3 splice site</arg>
              </example>
              <example src="EGRAM" no="21">
                <text>A pre-mRNA containing mutations in SE2, however, can be alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                <arg n="1">the nt 3605 3 splice site</arg>
              </example>
              <example src="EGRAM" no="22">
                <text>A pre-mRNA containing mutations in SE2, however, is able to alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                <arg n="1">the nt 3605 3 splice site</arg>
              </example>
              <example src="EGRAM" no="23">
                <text>A pre-mRNA containing mutations in SE2, however, is observed to be alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                <arg n="1">the nt 3605 3 splice site</arg>
              </example>
              <example src="EGRAM" no="24">
                <text>A pre-mRNA containing mutations in SE2, however, has been shown to be alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                <arg n="1">the nt 3605 3 splice site</arg>
              </example>
              <example src="EGRAM" no="25">
                <text>A pre-mRNA containing mutations in SE2, however, will be alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                <arg n="1">the nt 3605 3 splice site</arg>
              </example>
              <example src="EGRAM" no="25">
                <text>A pre-mRNA containing mutations in SE2, however, has the ability to be alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                <arg n="1">the nt 3605 3 splice site</arg>
              </example>
              <example src="EGRAM" no="25">
                <text>A pre-mRNA containing mutations in SE2, however, is likely to be alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                <arg n="1">the nt 3605 3 splice site</arg>
              </example>
                
                <example src="EGRAM" no="*26">
                    <text>The Supt4h gene has been spliced normally from five exons encoded by chromosome 11.</text>
                    <arg n="0">The Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="*27">
                    <text>The Supt4h gene was spliced normally from five exons encoded by chromosome 11.</text>
                    <arg n="0">The Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="*28">
                    <text>The Supt4h gene will be spliced normally from five exons encoded by chromosome 11.</text>
                    <arg n="0">The Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="*29">
                    <text>The Supt4h gene can be spliced normally from five exons encoded by chromosome 11.</text>
                    <arg n="0">The Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="*30">
                    <text>The Supt4h gene may be spliced normally from five exons encoded by chromosome 11.</text>
                    <arg n="0">The Supt4h gene</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="EGRAM" no="*31">
                    <text>The Supt4h gene may have been spliced normally from five exons encoded by chromosome 11.</text>
                    <arg n="0">The Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="*32">
                    <text>The Supt4h gene is likely to be spliced normally from five exons encoded by chromosome 11.</text>
                    <arg n="0">The Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="*32">
                    <text>The Supt4h gene is able to be spliced normally from five exons encoded by chromosome 11.</text>
                    <arg n="0">The Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="*32">
                    <text>The Supt4h gene is observed to be spliced normally from five exons encoded by chromosome 11.</text>
                    <arg n="0">The Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="*32">
                    <text>The Supt4h gene has been shown to be spliced normally from five exons encoded by chromosome 11.</text>
                    <arg n="0">The Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="*32">
                    <text>The Supt4h gene has the ability to be spliced normally from five exons encoded by chromosome 11.</text>
                    <arg n="0">The Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                
                <example src="EGRAM" no="*26">
                <text>The Supt4h gene has been normally spliced from five exons encoded by chromosome 11.</text>
                <arg n="0">The Supt4h gene</arg>
                <arg n="1">five exons encoded by chromosome 11</arg>
              </example>
              <example src="EGRAM" no="*27">
                <text>The Supt4h gene was normally spliced from five exons encoded by chromosome 11.</text>
                <arg n="0">The Supt4h gene</arg>
                <arg n="1">five exons encoded by chromosome 11</arg>
              </example>
              <example src="EGRAM" no="*28">
                <text>The Supt4h gene will be normally spliced from five exons encoded by chromosome 11.</text>
                <arg n="0">The Supt4h gene</arg>
                <arg n="1">five exons encoded by chromosome 11</arg>
              </example>
              <example src="EGRAM" no="*29">
                <text>The Supt4h gene can be normally spliced from five exons encoded by chromosome 11.</text>
                <arg n="0">The Supt4h gene</arg>
                <arg n="1">five exons encoded by chromosome 11</arg>
              </example>
              <example src="EGRAM" no="*30">
                <text>The Supt4h gene may be normally spliced from five exons encoded by chromosome 11.</text>
                <arg n="0">The Supt4h gene</arg>
                <arg n="1">five exons</arg>
              </example>
              <example src="EGRAM" no="*31">
                <text>The Supt4h gene may have been normally spliced from five exons encoded by chromosome 11.</text>
                <arg n="0">The Supt4h gene</arg>
                <arg n="1">five exons encoded by chromosome 11</arg>
              </example>
              <example src="EGRAM" no="*32">
                <text>The Supt4h gene is likely to be normally spliced from five exons encoded by chromosome 11.</text>
                <arg n="0">The Supt4h gene</arg>
                <arg n="1">five exons encoded by chromosome 11</arg>
              </example>
              <example src="EGRAM" no="*32">
                <text>The Supt4h gene is able to be normally spliced from five exons encoded by chromosome 11.</text>
                <arg n="0">The Supt4h gene</arg>
                <arg n="1">five exons encoded by chromosome 11</arg>
              </example>
              <example src="EGRAM" no="*32">
                <text>The Supt4h gene is observed to be normally spliced from five exons encoded by chromosome 11.</text>
                <arg n="0">The Supt4h gene</arg>
                <arg n="1">five exons encoded by chromosome 11</arg>
              </example>
              <example src="EGRAM" no="*32">
                <text>The Supt4h gene has been shown to be normally spliced from five exons encoded by chromosome 11.</text>
                <arg n="0">The Supt4h gene</arg>
                <arg n="1">five exons encoded by chromosome 11</arg>
              </example>
              <example src="EGRAM" no="*32">
                <text>The Supt4h gene has the ability to be normally spliced from five exons encoded by chromosome 11.</text>
                <arg n="0">The Supt4h gene</arg>
                <arg n="1">five exons encoded by chromosome 11</arg>
              </example>
                
                <example src="EGRAM" no="33">
                    <text>The casp-2 minigene (C2) has been spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">The casp-2 minigene (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="34">
                    <text>The casp-2 minigene (C2) is spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">The casp-2 minigene (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="35">
                    <text>The casp-2 minigene (C2) will be spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">The casp-2 minigene (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="36">
                    <text>The casp-2 minigene (C2) can be spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">The casp-2 minigene (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="37">
                    <text>The casp-2 minigene (C2) may have been spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">The casp-2 minigene (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="38">
                    <text>The casp-2 minigene (C2) is able to be spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">The casp-2 minigene (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="39">
                    <text>The casp-2 minigene (C2) is observed to be spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">The casp-2 minigene (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="39">
                    <text>The casp-2 minigene (C2) may have been shown to be spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">The casp-2 minigene (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="39">
                    <text>The casp-2 minigene (C2) has the ability to be spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">The casp-2 minigene (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="33">
                <text>The casp-2 minigene (C2) has been efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).</text>
                <arg n="0">The casp-2 minigene (C2)</arg>
                <arg n="3">in vitro</arg>
              </example>
              <example src="EGRAM" no="34">
                <text>The casp-2 minigene (C2) is efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).</text>
                <arg n="0">The casp-2 minigene (C2)</arg>
                <arg n="3">in vitro</arg>
              </example>
              <example src="EGRAM" no="35">
                <text>The casp-2 minigene (C2) will be efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).</text>
                <arg n="0">The casp-2 minigene (C2)</arg>
                <arg n="3">in vitro</arg>
              </example>
              <example src="EGRAM" no="36">
                <text>The casp-2 minigene (C2) can be efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).</text>
                <arg n="0">The casp-2 minigene (C2)</arg>
                <arg n="3">in vitro</arg>
              </example>
              <example src="EGRAM" no="37">
                <text>The casp-2 minigene (C2) may have been efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).</text>
                <arg n="0">The casp-2 minigene (C2)</arg>
                <arg n="3">in vitro</arg>
              </example>
              <example src="EGRAM" no="38">
                <text>The casp-2 minigene (C2) is able to be efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).</text>
                <arg n="0">The casp-2 minigene (C2)</arg>
                <arg n="3">in vitro</arg>
              </example>
              <example src="EGRAM" no="39">
                <text>The casp-2 minigene (C2) is observed to be efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).</text>
                <arg n="0">The casp-2 minigene (C2)</arg>
                <arg n="3">in vitro</arg>
              </example>
              <example src="EGRAM" no="39">
                <text>The casp-2 minigene (C2) may have been shown to be efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).</text>
                <arg n="0">The casp-2 minigene (C2)</arg>
                <arg n="3">in vitro</arg>
              </example>
              <example src="EGRAM" no="39">
                <text>The casp-2 minigene (C2) has the ability to be efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).</text>
                <arg n="0">The casp-2 minigene (C2)</arg>
                <arg n="3">in vitro</arg>
              </example>
                
                <example src="EGRAM" no="40">
                    <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that has been efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="40">
                    <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon having been efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="40">
                    <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="41">
                    <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that was efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="41">
                    <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon being efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="42">
                    <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that will be efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="42">
                    <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that can be efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="42">
                    <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that may have been efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="42">
                    <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that is able to be efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="42">
                    <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon being able to be efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="42">
                    <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that is observed to be efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="42">
                    <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon observed to be efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="42">
                    <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that has been shown to be efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="42">
                    <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon shown to be efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="42">
                    <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that has the ability to be efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="42">
                    <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon having the ability to be efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                
                                <example src="EGRAM" no="40">
                  <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that has been spliced efficiently into the mRNA.</text>
                  <arg n="1">a 654 nt exon</arg>
                  <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="40">
                  <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon having been spliced efficiently into the mRNA.</text>
                  <arg n="1">a 654 nt exon</arg>
                  <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="40">
                  <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon spliced efficiently into the mRNA.</text>
                  <arg n="1">a 654 nt exon</arg>
                  <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="41">
                  <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that was spliced efficiently into the mRNA.</text>
                  <arg n="1">a 654 nt exon</arg>
                  <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="41">
                  <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon being spliced efficiently into the mRNA.</text>
                  <arg n="1">a 654 nt exon</arg>
                  <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="42">
                  <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that will be spliced efficiently into the mRNA.</text>
                  <arg n="1">a 654 nt exon</arg>
                  <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="42">
                  <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that can be spliced efficiently into the mRNA.</text>
                  <arg n="1">a 654 nt exon</arg>
                  <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="42">
                  <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that may have been spliced efficiently into the mRNA.</text>
                  <arg n="1">a 654 nt exon</arg>
                  <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="42">
                  <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that is able to be spliced efficiently into the mRNA.</text>
                  <arg n="1">a 654 nt exon</arg>
                  <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="42">
                  <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon being able to be spliced efficiently into the mRNA.</text>
                  <arg n="1">a 654 nt exon</arg>
                  <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="42">
                  <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that is observed to be spliced efficiently into the mRNA.</text>
                  <arg n="1">a 654 nt exon</arg>
                  <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="42">
                  <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon observed to be spliced efficiently into the mRNA.</text>
                  <arg n="1">a 654 nt exon</arg>
                  <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="42">
                  <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that has been shown to be spliced efficiently into the mRNA.</text>
                  <arg n="1">a 654 nt exon</arg>
                  <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="42">
                  <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon shown to be spliced efficiently into the mRNA.</text>
                  <arg n="1">a 654 nt exon</arg>
                  <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="42">
                  <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that has the ability to be spliced efficiently into the mRNA.</text>
                  <arg n="1">a 654 nt exon</arg>
                  <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="42">
                  <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon having the ability to be spliced efficiently into the mRNA.</text>
                  <arg n="1">a 654 nt exon</arg>
                  <arg n="2">the mRNA</arg>
                </example>
                
                <example src="EGRAM" no="*43">
                    <text>The pre-mRNAs from all of these genes have been spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="EGRAM" no="*44">
                    <text>The pre-mRNAs from all of these genes were spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="EGRAM" no="*45">
                    <text>The pre-mRNAs from all of these genes will be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="EGRAM" no="*46">
                    <text>The pre-mRNAs from all of these genes can be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="EGRAM" no="*47">
                    <text>The pre-mRNAs from all of these genes may have been spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="EGRAM" no="*48">
                    <text>The pre-mRNAs from all of these genes are able to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="EGRAM" no="*48">
                    <text>The pre-mRNAs from all of these genes are observed to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="EGRAM" no="*48">
                    <text>The pre-mRNAs from all of these genes have been shown to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="EGRAM" no="*48">
                    <text>The pre-mRNAs from all of these genes have the ability to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                
                <example src="EGRAM" no="*43">
                    <text>The pre-mRNAs from all of these genes that have been spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="EGRAM" no="*43">
                    <text>The pre-mRNAs from all of these genes spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="EGRAM" no="*44">
                    <text>The pre-mRNAs from all of these genes that were spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="EGRAM" no="*45">
                    <text>The pre-mRNAs from all of these genes that will be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="EGRAM" no="*46">
                    <text>The pre-mRNAs from all of these genes that can be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="EGRAM" no="*47">
                    <text>The pre-mRNAs from all of these genes that may have been spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="EGRAM" no="*47">
                    <text>The pre-mRNAs from all of these genes having been spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="EGRAM" no="*48">
                    <text>The pre-mRNAs from all of these genes that are able to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="EGRAM" no="*48">
                    <text>The pre-mRNAs from all of these genes being able to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="EGRAM" no="*48">
                    <text>The pre-mRNAs from all of these genes that are observed to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="EGRAM" no="*48">
                    <text>The pre-mRNAs from all of these genes observed to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="EGRAM" no="*48">
                    <text>The pre-mRNAs from all of these genes that have been shown to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="EGRAM" no="*48">
                    <text>The pre-mRNAs from all of these genes shown to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="EGRAM" no="*48">
                    <text>The pre-mRNAs from all of these genes that have the ability to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="EGRAM" no="*48">
                    <text>The pre-mRNAs from all of these genes having the ability to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                
                <example src="EGRAM" no="49">
                    <text>The structure of different cDNA clones indicates that USF RNA has been differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="50">
                    <text>The structure of different cDNA clones indicates that USF RNA was differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="51">
                    <text>The structure of different cDNA clones indicates that USF RNA will be differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="51">
                    <text>The structure of different cDNA clones indicates that USF RNA can be differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="51">
                    <text>The structure of different cDNA clones indicates that USF RNA may have been differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="51">
                    <text>The structure of different cDNA clones indicates that USF RNA is able to be differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="51">
                    <text>The structure of different cDNA clones indicates that USF RNA is observed to be differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="51">
                    <text>The structure of different cDNA clones indicates that USF RNA has been shown to be differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="51">
                    <text>The structure of different cDNA clones indicates that USF RNA has the ability to be differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                            <example src="EGRAM" no="49">
              <text>The structure of different cDNA clones indicates that USF RNA has been spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
              <arg n="0">USF RNA</arg>
            </example>
            <example src="EGRAM" no="50">
              <text>The structure of different cDNA clones indicates that USF RNA was spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
              <arg n="0">USF RNA</arg>
            </example>
            <example src="EGRAM" no="51">
              <text>The structure of different cDNA clones indicates that USF RNA will be spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
              <arg n="0">USF RNA</arg>
            </example>
            <example src="EGRAM" no="51">
              <text>The structure of different cDNA clones indicates that USF RNA can be spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
              <arg n="0">USF RNA</arg>
            </example>
            <example src="EGRAM" no="51">
              <text>The structure of different cDNA clones indicates that USF RNA may have been spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
              <arg n="0">USF RNA</arg>
            </example>
            <example src="EGRAM" no="51">
              <text>The structure of different cDNA clones indicates that USF RNA is able to be spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
              <arg n="0">USF RNA</arg>
            </example>
            <example src="EGRAM" no="51">
              <text>The structure of different cDNA clones indicates that USF RNA is observed to be spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
              <arg n="0">USF RNA</arg>
            </example>
            <example src="EGRAM" no="51">
              <text>The structure of different cDNA clones indicates that USF RNA has been shown to be spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
              <arg n="0">USF RNA</arg>
            </example>
            <example src="EGRAM" no="51">
              <text>The structure of different cDNA clones indicates that USF RNA has the ability to be spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
              <arg n="0">USF RNA</arg>
            </example>
                
                <example src="EGRAM" no="52">
                    <text>We also identified four transcriptional units that have been spliced but contained no obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="52">
                    <text>We also identified four transcriptional units spliced but containing no obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="53">
                    <text>We also identified four transcriptional units that were spliced but contained no obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="54">
                    <text>We also identified four transcriptional units that will be spliced but contain no obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="54">
                    <text>We also identified four transcriptional units that can be spliced but contain no obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="54">
                    <text>We also identified four transcriptional units that may be spliced but contain no obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="54">
                    <text>We also identified four transcriptional units that may have been spliced but contained no obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="54">
                    <text>We also identified four transcriptional units that could have been spliced but contained no obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="54">
                    <text>We also identified four transcriptional units that are able to be spliced but contain no obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="54">
                    <text>We also identified four transcriptional units being able to be spliced but containing no obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="54">
                    <text>We also identified four transcriptional units that are observed to be spliced but contain no obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="54">
                    <text>We also identified four transcriptional units observed to be spliced but containing no obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="54">
                    <text>We also identified four transcriptional units that have been shown to be spliced but contained no obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="54">
                    <text>We also identified four transcriptional units having been shown to be spliced but containing no obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                
                              <example src="EGRAM" no="52">
                <text>We also identified four transcriptional units that have been differentially spliced but contained no obvious open reading frame.</text>
                <arg n="0">four transcriptional units</arg>
              </example>
              <example src="EGRAM" no="52">
                <text>We also identified four transcriptional units differentially spliced but containing no obvious open reading frame.</text>
                <arg n="0">four transcriptional units</arg>
              </example>
              <example src="EGRAM" no="53">
                <text>We also identified four transcriptional units that were differentially spliced but contained no obvious open reading frame.</text>
                <arg n="0">four transcriptional units</arg>
              </example>
              <example src="EGRAM" no="54">
                <text>We also identified four transcriptional units that will be differentially spliced but contain no obvious open reading frame.</text>
                <arg n="0">four transcriptional units</arg>
              </example>
              <example src="EGRAM" no="54">
                <text>We also identified four transcriptional units that can be differentially spliced but contain no obvious open reading frame.</text>
                <arg n="0">four transcriptional units</arg>
              </example>
              <example src="EGRAM" no="54">
                <text>We also identified four transcriptional units that may be differentially spliced but contain no obvious open reading frame.</text>
                <arg n="0">four transcriptional units</arg>
              </example>
              <example src="EGRAM" no="54">
                <text>We also identified four transcriptional units that may have been differentially spliced but contained no obvious open reading frame.</text>
                <arg n="0">four transcriptional units</arg>
              </example>
              <example src="EGRAM" no="54">
                <text>We also identified four transcriptional units that could have been differentially spliced but contained no obvious open reading frame.</text>
                <arg n="0">four transcriptional units</arg>
              </example>
              <example src="EGRAM" no="54">
                <text>We also identified four transcriptional units that are able to be differentially spliced but contain no obvious open reading frame.</text>
                <arg n="0">four transcriptional units</arg>
              </example>
              <example src="EGRAM" no="54">
                <text>We also identified four transcriptional units being able to be differentially spliced but containing no obvious open reading frame.</text>
                <arg n="0">four transcriptional units</arg>
              </example>
              <example src="EGRAM" no="54">
                <text>We also identified four transcriptional units that are observed to be differentially spliced but contain no obvious open reading frame.</text>
                <arg n="0">four transcriptional units</arg>
              </example>
              <example src="EGRAM" no="54">
                <text>We also identified four transcriptional units observed to be differentially spliced but containing no obvious open reading frame.</text>
                <arg n="0">four transcriptional units</arg>
              </example>
              <example src="EGRAM" no="54">
                <text>We also identified four transcriptional units that have been shown to be differentially spliced but contained no obvious open reading frame.</text>
                <arg n="0">four transcriptional units</arg>
              </example>
              <example src="EGRAM" no="54">
                <text>We also identified four transcriptional units having been shown to be differentially spliced but containing no obvious open reading frame.</text>
                <arg n="0">four transcriptional units</arg>
              </example>
                
                <example src="EGRAM" no="*55">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate has been spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                    <arg n="0">the C2Gloi2 substrate</arg>
                    <arg n="1">the exon-skipping pathway</arg>
                </example>
                <example src="EGRAM" no="*56">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate is spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                    <arg n="0">the C2Gloi2 substrate</arg>
                    <arg n="1">the exon-skipping pathway</arg>
                </example>
                <example src="EGRAM" no="*57">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate can be spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                    <arg n="0">the C2Gloi2 substrate</arg>
                    <arg n="1">the exon-skipping pathway</arg>
                </example>
                <example src="EGRAM" no="*58">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate will be spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                    <arg n="0">the C2Gloi2 substrate</arg>
                    <arg n="1">the exon-skipping pathway</arg>
                </example>
                <example src="EGRAM" no="*59">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate may be spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                    <arg n="0">the C2Gloi2 substrate</arg>
                    <arg n="1">the exon-skipping pathway</arg>
                </example>
                <example src="EGRAM" no="*60">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate may have been spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                    <arg n="0">the C2Gloi2 substrate</arg>
                    <arg n="1">the exon-skipping pathway</arg>
                </example>
                <example src="EGRAM" no="*60">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate is able to be spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                    <arg n="0">the C2Gloi2 substrate</arg>
                    <arg n="1">the exon-skipping pathway</arg>
                </example>
                <example src="EGRAM" no="*60">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate is observed to be spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                    <arg n="0">the C2Gloi2 substrate</arg>
                    <arg n="1">the exon-skipping pathway</arg>
                </example>
                <example src="EGRAM" no="*60">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate has been shown to be spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                    <arg n="0">the C2Gloi2 substrate</arg>
                    <arg n="1">the exon-skipping pathway</arg>
                </example>
                <example src="EGRAM" no="*60">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate has the ablity to be spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                    <arg n="0">the C2Gloi2 substrate</arg>
                    <arg n="1">the exon-skipping pathway</arg>
                </example>
                              <example src="EGRAM" no="*55">
                <text>When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate has been spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                <arg n="0">the C2Gloi2 substrate</arg>
                <arg n="1">the exon-skipping pathway</arg>
              </example>
              <example src="EGRAM" no="*56">
                <text>When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate is spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                <arg n="0">the C2Gloi2 substrate</arg>
                <arg n="1">the exon-skipping pathway</arg>
              </example>
              <example src="EGRAM" no="*57">
                <text>When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate can be spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                <arg n="0">the C2Gloi2 substrate</arg>
                <arg n="1">the exon-skipping pathway</arg>
              </example>
              <example src="EGRAM" no="*58">
                <text>When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate will be spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                <arg n="0">the C2Gloi2 substrate</arg>
                <arg n="1">the exon-skipping pathway</arg>
              </example>
              <example src="EGRAM" no="*59">
                <text>When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate may be spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                <arg n="0">the C2Gloi2 substrate</arg>
                <arg n="1">the exon-skipping pathway</arg>
              </example>
              <example src="EGRAM" no="*60">
                <text>When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate may have been spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                <arg n="0">the C2Gloi2 substrate</arg>
                <arg n="1">the exon-skipping pathway</arg>
              </example>
              <example src="EGRAM" no="*60">
                <text>When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate is able to be spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                <arg n="0">the C2Gloi2 substrate</arg>
                <arg n="1">the exon-skipping pathway</arg>
              </example>
              <example src="EGRAM" no="*60">
                <text>When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate is observed to be spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                <arg n="0">the C2Gloi2 substrate</arg>
                <arg n="1">the exon-skipping pathway</arg>
              </example>
              <example src="EGRAM" no="*60">
                <text>When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate has been shown to be spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                <arg n="0">the C2Gloi2 substrate</arg>
                <arg n="1">the exon-skipping pathway</arg>
              </example>
              <example src="EGRAM" no="*60">
                <text>When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate has the ablity to be spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                <arg n="0">the C2Gloi2 substrate</arg>
                <arg n="1">the exon-skipping pathway</arg>
              </example>              
            </roleset>
         </predicate>
    </framesest>
</PASBIO>
